Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant changes » significant challenge (Expand Search)
significant genes » significant gender (Expand Search), significant benefits (Expand Search), significant gap (Expand Search)
Showing 1,621 - 1,640 results of 21,342 for search '(( significant decrease decrease ) OR ( ((significant genes) OR (significant changes)) decrease ))', query time: 0.70s Refine Results
  1. 1621
    Demographic characteristics of the breast cancer patients enrolled in the study.

    Demographic characteristics of the breast cancer patients enrolled in the study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1622
    FPRP values for the association between rs12529 and breast cancer risk.

    FPRP values for the association between rs12529 and breast cancer risk. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1623
    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH).

    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1624
    Representative restriction enzyme-digested products on a 2% agarose gel.

    Representative restriction enzyme-digested products on a 2% agarose gel. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1625
    Baseline characteristics of study subjects.

    Baseline characteristics of study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1626
    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH).

    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1627
    Functional effects of rs12529 (H5Q) on the AKR1C3 protein.

    Functional effects of rs12529 (H5Q) on the AKR1C3 protein. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1628
    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status.

    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1629
    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects.

    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1630
    The clinicopathological information of the patients involved in this study.

    The clinicopathological information of the patients involved in this study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 1631
    Genotypic distribution of rs12529 in the study subjects.

    Genotypic distribution of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 1632
    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 1633
    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 1634
    (A) Cardiovascular Disease and (B) type-2 Diabetes Mellitus, and (C) chronic kidney disease- related Age-Adjusted Mortality Rates per 100,000 in Adults in the United States, 1999 to 2022. * Indicates that the APC is significantly different from zero at α = 0.05. AAMR = age-adjusted mortality rate; APC = annual percent change; CI = confidence interval.

    (A) Cardiovascular Disease and (B) type-2 Diabetes Mellitus, and (C) chronic kidney disease- related Age-Adjusted Mortality Rates per 100,000 in Adults in the United States, 1999 t... by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 1635
    Sex differences and percentage change trends in smoking-attributable RA burden from 1990 to 2021.

    Sex differences and percentage change trends in smoking-attributable RA burden from 1990 to 2021. by Kaibin Lin (9911049)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 1636
    Cnot4 Het does not affect mRNA expression of metabolic genes as well as serum lipid levels or glucose tolerance.

    Cnot4 Het does not affect mRNA expression of metabolic genes as well as serum lipid levels or glucose tolerance. by Tomokazu Yamaguchi (8284989)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1637
    Changes in bioimpedance by sex.

    Changes in bioimpedance by sex. by Domingos L. S. Rios (20496173)

    Published 2025
    “…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. Conclusion: This study suggests the viability of treating severe obesity by hospitalization with low-calorie diets and immersive lifestyle changes. …”
    Save to List
    Saved in:
  18. 1638
    Changes in bioimpedance by age.

    Changes in bioimpedance by age. by Domingos L. S. Rios (20496173)

    Published 2025
    “…Elderly individuals (aged ≥ 60 years) had smaller reductions in BMI and fat mass than non-elderly individuals (aged < 60 years) but still presented significant improvements. Conclusion: This study suggests the viability of treating severe obesity by hospitalization with low-calorie diets and immersive lifestyle changes. …”
    Save to List
    Saved in:
  19. 1639
    Comparison of the cohesion ranges of different food categories under IDDSI levels.

    Comparison of the cohesion ranges of different food categories under IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1640
    Relationships between cohesiveness and IDDSI levels.

    Relationships between cohesiveness and IDDSI levels. by Muxi Chen (9294270)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: